Coronavirus replicase-reporter fusions provide quantitative analysis of replication and replication complex formation

Journal of Virology

Volumn 88, Issue 10, 2014, Pages 5319-5327

  Freeman, Megan Culler ^a   Graham, Rachel L ^b   Lu, Xiaotao ^a   Peek, Christopher T ^a   Denison, Mark R ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b University of North Carolina at Chapel Hill   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORONAVIRUS REPLICASE; FIREFLY LUCIFERASE; GREEN FLUORESCENT PROTEIN; MESSENGER RNA; NONSTRUCTURAL PROTEIN 1; NONSTRUCTURAL PROTEIN 2; UNCLASSIFIED DRUG; VIRUS ENZYME;

ARTICLE; CELLULAR DISTRIBUTION; COMPLEX FORMATION; CONTROLLED STUDY; CORONAVIRUS; ENZYME ACTIVITY; GENE FUSION; GENE REPLICATION; HEPATITIS VIRUS; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; SENSITIVITY AND SPECIFICITY; VIRUS GENE; VIRUS REPLICATION;

ANIMALS; ARTIFICIAL GENE FUSION; CELL LINE; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; MURINE HEPATITIS VIRUS; RECOMBINANT FUSION PROTEINS; RNA REPLICASE; STAINING AND LABELING; VIRUS REPLICATION;

EID: 84899070072     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00021-14     Document Type: Article

References (48)

1. Perlman S, Netland J. 2009. Coronaviruses post-SARS: update on replication and pathogenesis. Nat. Rev. Microbiol. 7:439-450. http://dx.doi.org/10.1038/nrmicro2147.
2. Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, Tong S, Urbani C, Comer JA, Lim W, Rollin PE, Dowell SF, Ling AE, Humphrey CD, Shieh WJ, Guarner J, Paddock CD, Rota P, Fields B, DeRisi J, Yang JY, Cox N, Hughes JM, LeDuc JW, Bellini WJ, Anderson LJ. 2003. A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 348:1953-1966. http://dx.doi.org/10.1056 /NEJMoa030781.
3. Peiris JS, Lai ST, Poon LL, Guan Y, Yam LY, Lim W, Nicholls J, Yee WK, Yan WW, Cheung MT, Cheng VC, Chan KH, Tsang DN, Yung RW, Ng TK, Yuen KY. 2003. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361:1319-1325. http://dx.doi.org/10 .1016/S0140-6736(03)13077-2.
4. Rota PA, Oberste MS, Monroe SS, Nix WA, Campagnoli R, Icenogle JP, Penaranda S, Bankamp B, Maher K, Chen MH, Tong S, Tamin A, Lowe L, Frace M, DeRisi JL, Chen Q, Wang D, Erdman DD, Peret TC, Burns C, Ksiazek TG, Rollin PE, Sanchez A, Liffick S, Holloway B, Limor J, McCaustland K, Olsen-Rasmussen M, Fouchier R, Gunther S, Osterhaus AD, Drosten C, Pallansch MA, Anderson LJ, Bellini WJ. 2003. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 300:1394-1399. http://dx.doi.org/10.1126 /science.1085952.
5. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. 2012. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N. Engl. J. Med. 367:1814-1820. http://dx.doi.org/10.1056 /NEJMoa1211721.
6. Angelini MM, Akhlaghpour M, Neuman BW, Buchmeier MJ. 2013. Severe acute respiratory syndrome coronavirus nonstructural proteins 3, 4, and 6 induce double-membrane vesicles. mBio 4(4):pii 00524-13. http://dx.doi.org/10.1128/mBio.00524-13.
7. Gosert R, Kanjanahaluethai A, Egger D, Bienz K, Baker SC. 2002. RNA replication of mouse hepatitis virus takes place at double-membrane vesicles. J. Virol. 76:3697-3708. http://dx.doi.org/10.1128/JVI.76.8.3697 -3708.2002.
8. Knoops K, Kikkert M, Worm SH, Zevenhoven-Dobbe JC, van der Meer Y, Koster AJ, Mommaas AM, Snijder EJ. 2008. SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum. PLoS Biol. 6:e226. http://dx.doi.org/10.1371/journal.pbio .0060226.
9. Ulasli M, Verheije MH, de Haan CA, Reggiori F. 2010. Qualitative and quantitative ultrastructural analysis of the membrane rearrangements induced by coronavirus. Cell. Microbiol. 12:844-861. http://dx.doi.org/10 .1111/j.1462-5822.2010.01437.x.
10. Snijder EJ, van der Meer Y, Zevenhoven-Dobbe J, Onderwater JJ, van der Meulen J, Koerten HK, Mommaas AM. 2006. Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex. J. Virol. 80:5927-5940. http: //dx.doi.org/10.1128/JVI.02501-05.
11. Bost AG, Carnahan RH, Lu XT, Denison MR. 2000. Four proteins processed from the replicase gene polyprotein of mouse hepatitis virus colocalize in the cell periphery and adjacent to sites of virion assembly. J. Virol. 74:3379- 3387. http://dx.doi.org/10.1128/JVI.74.7.3379-3387.2000.
12. Brockway SM, Clay CT, Lu XT, Denison MR. 2003. Characterization of the expression, intracellular localization, and replication complex association of the putative mouse hepatitis virus RNA-dependent RNA polymerase. J. Virol. 77:10515-10527. http://dx.doi.org/10.1128/JVI.77.19 .10515-10527.2003.
13. van der Meer Y, Snijder EJ, Dobbe JC, Schleich S, Denison MR, Spaan WJ, Locker JK. 1999. Localization of mouse hepatitis virus nonstructural proteins and RNA synthesis indicates a role for late endosomes in viral replication. J. Virol. 73:7641-7657.
14. Bost AG, Prentice E, Denison MR. 2001. Mouse hepatitis virus replicase protein complexes are translocated to sites of M protein accumulation in the ergic at late times of infection Virology 285:21-29. http://dx.doi.org/10.1006/viro.2001.0932
15. Sims AC, Ostermann J, Denison MR. 2000. Mouse hepatitis virus replicase proteins associate with two distinct populations of intracellular membranes. J. Virol. 74:5647-5654. http://dx.doi.org/10.1128/JVI.74.12 .5647-5654.2000.
16. Brockway SM, Lu XT, Peters TR, Dermody TS, Denison MR. 2004. Intracellular localization and protein interactions of the gene 1 protein p28 during mouse hepatitis virus replication. J. Virol. 78:11551-11562. http://dx.doi.org/10.1128/JVI.78.21.11551-11562.2004.
17. Bosch BJ, de Haan CA, Rottier PJ. 2004. Coronavirus spike glycoprotein, extended at the carboxy terminus with green fluorescent protein, is assembly competent. J. Virol. 78:7369-7378. http://dx.doi.org/10.1128/JVI.78 .14.7369-7378.2004.
18. Das Sarma J, Scheen E, Seo SH, Koval M, Weiss SR. 2002. Enhanced green fluorescent protein expression may be used to monitor murine coronavirus spread in vitro and in the mouse central nervous system. J. Neurovirol. 8:381-391. http://dx.doi.org/10.1080/13550280260422686.
19. de Haan CA, van Genne L, Stoop JN, Volders H, Rottier PJ. 2003. Coronaviruses as vectors: position dependence of foreign gene expression. J. Virol. 77:11312-11323. http://dx.doi.org/10.1128/JVI.77.21.11312 -11323.2003.
20. Fischer F, Stegen CF, Koetzner CA, Masters PS. 1998. Construction of a mouse hepatitis virus recombinant expressing a foreign gene. Adv. Exp. Med. Biol. 440:291-295.
21. Hertzig T, Scandella E, Schelle B, Ziebuhr J, Siddell SG, Ludewig B, Thiel V. 2004. Rapid identification of coronavirus replicase inhibitors using a selectable replicon RNA J. Gen. Virol. 85:1717-1725. http://dx.doi .org/10.1099/vir.0.80044-0.
22. Ge F, Luo Y, Liew PX, Hung E. 2007. Derivation of a novel SARScoronavirus replicon cell line and its application for anti-SARS drug screening. Virology 360:150-158. http://dx.doi.org/10.1016/j.virol.2006 .10.016.
23. Roberts RS, Yount BL, Sims AC, Baker S, Baric RS. 2006. Renilla luciferase as a reporter to assess SARS-CoV mRNA transcription regulation and efficacy of anti-SARS-CoV agents. Adv. Exp. Med. Biol. 581:597- 600. http://dx.doi.org/10.1007/978-0-387-33012-9_108.
24. Zhao G, Du L, Ma C, Li Y, Li L, Poon VK, Wang L, Yu F, Zheng BJ, Jiang S, Zhou Y. 2013. A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV. Virol. J. 10: 266. http://dx.doi.org/10.1186/1743-422X-10-266.
25. van den Born E, Posthuma CC, Knoops K, Snijder EJ. 2007. An infectious recombinant equine arteritis virus expressing green fluorescent protein from its replicase gene. J. Gen. Virol. 88:1196-1205. http://dx.doi .org/10.1099/vir.0.82590-0.
26. Graham RL, Sims AC, Brockway SM, Baric RS, Denison MR. 2005. The nsp2 replicase proteins of murine hepatitis virus and severe acute respiratory syndrome coronavirus are dispensable for viral replication. J. Virol. 79:13399-13411. http://dx.doi.org/10.1128/JVI.79.21.13399-13411.2005.
27. Sperry SM, Kazi L, Graham RL, Baric RS, Weiss SR, Denison MR. 2005. Single-amino-acid substitutions in open reading frame (ORF) 1b-nsp14 and ORF 2a proteins of the coronavirus mouse hepatitis virus are attenuating in mice. J. Virol. 79:3391-3400. http://dx.doi.org/10.1128/JVI.79.6 .3391-3400.2005.
28. Denison MR, Yount B, Brockway SM, Graham RL, Sims AC, Lu X, Baric RS. 2004. Cleavage between replicase proteins p28 and p65 of mouse hepatitis virus is not required for virus replication. J. Virol. 78:5957-5965. http://dx.doi.org/10.1128/JVI.78.11.5957-5965.2004.
29. Hirano N, Fujiwara K, Matumoto M. 1976. Mouse hepatitis virus (MHV-2). Plaque assay and propagation in mouse cell line DBT cells. Jpn. J. Microbiol. 20:219-225.
30. Lin HH, Kao JH, Chen PJ, Chen DS. 1996. Mechanism of vertical transmission of hepatitis G Lancet 347:1116. http://dx.doi.org/10.1016 /S0140-6736(96)90314-1.
31. Chen W, Madden VJ, Bagnell CR, Jr, Baric RS. 1997. Host-derived intracellular immunization against mouse hepatitis virus infection. Virology 228:318-332. http://dx.doi.org/10.1006/viro.1996.8402.
32. Reference deleted.
33. Yount B, Denison MR, Weiss SR, Baric RS. 2002. Systematic assembly of a full-length infectious cDNA of mouse hepatitis virus strain A59. J. Virol. 76:11065-11078. http://dx.doi.org/10.1128/JVI.76.21.11065-11078.2002.
34. Yount B, Curtis KM, Fritz EA, Hensley LE, Jahrling PB, Prentice E, Denison MR, Geisbert TW, Baric RS. 2003. Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus. Proc. Natl. Acad. Sci. U. S. A. 100:12995-13000. http://dx.doi.org /10.1073/pnas.1735582100.
35. Lavi E, Gilden DH, Wroblewska Z, Rorke LB, Weiss SR. 1984. Experimental demyelination produced by the A59 strain of mouse hepatitis virus. Neurology 34:597-603. http://dx.doi.org/10.1212/WNL.34.5.597.
36. Graham RL, Denison MR. 2006. Replication of murine hepatitis virus is regulated by papain-like proteinase 1 processing of nonstructural proteins 1, 2, and 3. J. Virol. 80:11610-11620. http://dx.doi.org/10.1128/JVI.01428-06.
37. Gadlage MJ, Denison MR. 2010. Exchange of the coronavirus replicase polyprotein cleavage sites alters protease specificity and processing. J. Virol. 84:6894-6898. http://dx.doi.org/10.1128/JVI.00752-10.
38. Burgess A, Vigneron S, Brioudes E, Labbe JC, Lorca T, Castro A. 2010. Loss of human greatwall results in G2 arrest and multiple mitotic defects due to deregulation of the cyclin B-Cdc2/PP2A balance. Proc. Natl. Acad. Sci. U. S. A. 107:12564-12569. http://dx.doi.org/10.1073/pnas.0914191107.
39. Curtis KM, Yount B, Baric RS. 2002. Heterologous gene expression from transmissible gastroenteritis virus replicon particles. J. Virol. 76:1422- 1434. http://dx.doi.org/10.1128/JVI.76.3.1422-1434.2002.
40. Kilianski A, Mielech AM, Deng X, Baker SC. 2013. Assessing activity and inhibition of Middle East respiratory syndrome coronavirus papain-like and 3C-like proteases using luciferase-based biosensors. J. Virol. 87: 11955-11962. http://dx.doi.org/10.1128/JVI.02105-13.
41. Pfefferle S, Schopf J, Kogl M, Friedel CC, Muller MA, Carbajo-Lozoya J, Stellberger T, von Dall'Armi E, Herzog P, Kallies S, Niemeyer D, Ditt V, Kuri T, Zust R, Pumpor K, Hilgenfeld R, Schwarz F, Zimmer R, Steffen I, Weber F, Thiel V, Herrler G, Thiel HJ, Schwegmann-Wessels C, Pohlmann S, Haas J, Drosten C, von Brunn A. 2011. The SARScoronavirus- host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors. PLoS Pathog. 7:e1002331. http://dx.doi.org /10.1371/journal.ppat.1002331.
42. Hagemeijer MC, Verheije MH, Ulasli M, Shaltiel IA, de Vries LA, Reggiori F, Rottier PJ, de Haan CA. 2010. Dynamics of coronavirus replication-transcription complexes. J. Virol. 84:2134-2149. http://dx.doi .org/10.1128/JVI.01716-09.
43. Hagemeijer MC, Ulasli M, Vonk AM, Reggiori F, Rottier PJ, de Haan CA. 2011. Mobility and interactions of coronavirus nonstructural protein 4. J. Virol. 85:4572-4577. http://dx.doi.org/10.1128/JVI.00042-11.
44. Gadlage MJ, Graham RL, Denison MR. 2008. Murine coronaviruses encoding nsp2 at different genomic loci have altered replication, protein expression, and localization. J. Virol. 82:11964-11969. http://dx.doi.org/10.1128/JVI.01126-07.
45. Lauber C, Goeman JJ, Parquet MC, Nga PT, Snijder EJ, Morita K, Gorbalenya AE. 2013. The footprint of genome architecture in the largest genome expansion in RNA viruses. PLoS Pathog. 9:e1003500. http://dx .doi.org/10.1371/journal.ppat.1003500.
46. Somogyi P, Jenner AJ, Brierley I, Inglis SC. 1993. Ribosomal pausing during translation of an RNA pseudoknot. Mol. Cell. Biol. 13:6931-6940.
47. Plant EP, Perez-Alvarado GC, Jacobs JL, Mukhopadhyay B, Hennig M, Dinman JD. 2005. A three-stemmed mRNA pseudoknot in the SARS coronavirus frameshift signal PLoS Biol. 3:e172. http://dx.doi.org/10 .1371/journal.pbio.0030172.
48. Plant EP, Sims AC, Baric RS, Dinman JD, Taylor DR. 2013. Altering SARS coronavirus frameshift efficiency affects genomic and subgenomic RNA production. Viruses 5:279-294. http://dx.doi.org/10.3390/v5010279.